ahlam1399
10-01-2016, 04:52 AM
UPDATE 1-Depomed wins Nucynta patent dispute; may spur sale talks
Sept 30 (Reuters) - A court ruled in Depomed Inc's favor in a patent dispute over its opioid drug, Nucynta, adecision that could help pave the way for the drug maker toexplore a sale.http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=cD3nkXEytLA:LYyM7WG1NjU:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=cD3nkXEytLA:LYyM7WG1NjU:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=cD3nkXEytLA:LYyM7WG1NjU:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=cD3nkXEytLA:LYyM7WG1NjU:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=cD3nkXEytLA:LYyM7WG1NjU:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/cD3nkXEytLA
Sept 30 (Reuters) - A court ruled in Depomed Inc's favor in a patent dispute over its opioid drug, Nucynta, adecision that could help pave the way for the drug maker toexplore a sale.http://feeds.feedburner.com/~ff/reuters/hotStocksNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=cD3nkXEytLA:LYyM7WG1NjU:yIl2AUoC8z A) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=cD3nkXEytLA:LYyM7WG1NjU:F7zBnMyn0L o (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=cD3nkXEytLA:LYyM7WG1NjU:F7zBnMyn0L o) http://feeds.feedburner.com/~ff/reuters/hotStocksNews?i=cD3nkXEytLA:LYyM7WG1NjU:V_sGLiPBpW U (http://feeds.reuters.com/~ff/reuters/hotStocksNews?a=cD3nkXEytLA:LYyM7WG1NjU:V_sGLiPBpW U)
http://feeds.feedburner.com/~r/reuters/hotStocksNews/~4/cD3nkXEytLA